Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
Prof. Gil Wolfe summarizes his findings from his study on the long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis. Read the paper ...
15 Jul 20192min
Neurology Residency Programs & Training
Dr. Jeffrey Ratliff discusses neurology residency programs, training, and action by the consortium of residency program directors.
12 Jul 20191min
MuSK Myasthenia Gravis
Dr. Ted Burns discusses clinical recognition and diagnosis of MuSK myasthenia gravis.
11 Jul 20192min
Continuum Pearls: Pregnancy and Family Planning in Multiple Sclerosis, pt. 3
Dr. Annette Langer-Gould discusses pregnancy and family planning with MS in the third of a three-part series. To learn more, read the article "Pregnancy and Family Planning in Multiple Sclerosis" by D...
10 Jul 20191min
Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease
Dr. Franziska Hopfner talks about the main takeaways from her paper on the use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.
9 Jul 20191min
First Cannabis-Derived Pharmaceutical
Dr. Jerzy Szaflarski talks about the FDA's approval of the first cannabis-derived pharmaceutical for the treatment of epilepsy and Lennox-Gastaut syndrome in particular. For more, read the full articl...
8 Jul 20191min
Sports Concussion Conference 2019
Co-director Dr. Brian Hainline talks about new features and highlights of the 2019 AAN Sports Concussion Conference. The conference takes place July 26-28 in Indianapolis.
5 Jul 20192min
Continuum Pearls: Pregnancy and Family Planning in MS, pt. 2
Dr. Annette Langer-Gould discusses pregnancy and family planning with MS in the second part of a three-part series. To learn more, read the article "Pregnancy and Family Planning in Multiple Sclerosis...
4 Jul 20192min
